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ABSTRACT: Anti-nuclear antibody expression and its relationship to severity of illness, organ 
dysfunction and outcomes in Scrub typhus. !!
OBJECTIVES OF THE STUDY: !
1. To estimate the prevalence of anti-nuclear antibody expression in Scrub typhus, in comparison 
to patients with other acute infective febrile illnesses. 
2. To study the patterns of anti-nuclear antibodies expressed in Scrub typhus. 
3. To study the influence of antinuclear auto-antibodies on organ dysfunction, hospitalisation and 
outcomes in Scrub typhus. 
4. To study the predictive value of ANA in Scrub typhus. 
METHODS: 
This prospective, observational cohort study was conducted in the Department of General Medicine 
of a tertiary care hospital between January, 2013 and January, 2014. Adult patients hospitalised in 
the medical wards with an acute febrile illness(AFI), fulfilling the diagnostic criteria for Scrub 
typhus infection[89 cases] and other acute infective febrile illnesses[60 controls] were included in 
the study. After obtaining a written consent from patients fulfilling the inclusion criteria, the 
necessary demographic data and the data regarding the current illness and investigations were 
collected. Patients and controls were tested for the presence of antinuclear antibodies immediately 
after admission. Severity of the illness was measured using scoring systems such as APACHE III 
and SOFA and its correlation with ANA positivity was studied. Patients were also assessed for 
complications of scrub typhus along with need for ventilation and use of vasoactive agents. 
Duration of hospital stay, duration of ICU stay and hospital outcomes were assessed along with 
their correlation to ANA positivity. Patients with antinuclear antibodies were followed up after a 
period of 6 weeks and repeat ANA testing was done. Descriptive and bivariate analysis was done. 
!
!
RESULTS: 
89 cases of scrub typhus and 60 controls with other acute infective febrile illnesses were included in 
the study. The prevalence of antinuclear antibodies was 53.93% in scrub typhus patients and 15% in 
patients with other acute febrile illnesses(p <0.01). On testing after a period of 6 weeks, antinuclear 
antibodies persisted to be present in 15.6% patients with scrub typhus. The speckled pattern of 
antinuclear antibodies was most commonly seen(93.75%). On bivariate analysis, the APACHE III 
scores and antinuclear antibody positivity showed correlation which was tending towards statistical 
significance. [OR-1.01, p-0.07]. There was also a positive correlation with antinuclear antibodies in 
scrub typhus and the development of acute respiratory distress syndrome [OR-2.44, p-0.04], central 
nervous system manifestations[OR-6.65, p-0.08] and liver dysfunction[OR-2.25, p-0.06]. However, 
no correlation was found between the presence of antinuclear antibodies and SOFA scores, duration 
of hospital stay, duration of ICU stay and mortality in scrub typhus. 
CONCLUSIONS: 
Antinuclear antibodies were found in a significant proportion of patients with scrub typhus and the 
speckled pattern was commonly expressed. This appears to be related to the acute phase of illness 
and these antibodies showed a positive correlation with severity of illness as assessed by the 
APACHE III scoring system, respiratory, neurological and hepatic manifestations. Presence of these 
antibodies showed no correlation with duration of hospital stay and ICU stay. Further studies are 
needed for better understanding of this phenomenon. 
!
!
!
!
!
INTRODUCTION 
Scrub typhus is a zoonotic disease. Orientia tsutsugamushi, the causative organism of Scrub typhus, 
is a Gram-negative, obligate intracellular parasite. The organism is transmitted to humans by the 
bite of the larval form(chigger) of the trombiculid mite, Leptotrombidium species.(1) 
Infection results in an acute febrile illness. This illness is endemic to South East Asia, the Asia-Pa-
cific region and northern Australia, also called the Tsutsugamushi triangle.(2) The pathophysiology 
is that of a focal and disseminated vasculitis which results in its protean manifestations. Prolifera-
tion of the organism in the endothelium of small blood vessels results in endothelial disruption 
which causes fluid leak, platelet aggregation and neutrophil proliferation. This leads to microinfarc-
tions, secondary to the focal occlusive angiitis.(3)  
Commonly seen during the cooler months, Scrub typhus constitutes 47.5% of the cases of acute un-
differentiated febrile illness in South India.(4) Course of illness can vary from a simple febrile ill-
ness with early defervescence to a devastating disease with multisystem involvement and signifi-
cant morbidity and mortality. It has a high case fatality rate, although recent studies have depicted a 
downward trend in case fatality. (5,6)   
Pathogenesis of this disease is poorly understood and factors affecting outcomes are not well stud-
ied. Unpublished data from the ICU of a tertiary care hospital in South India has detected the pres-
ence of antinuclear antibodies in the serum of patients who present with Scrub typhus. The reason 
for this is not clear and its effect on morbidity and mortality is not known. We postulate that patients 
who manifest multi organ dysfunction in severe Scrub typhus may have a nonspecific expression of 
this immunological marker. It would also be of prognostic significance to evaluate if the non-specif-
!  14
ic expression of this antibody is associated with a higher incidence of organ dysfunction and poorer 
outcomes. Further studies to understand this phenomenon are warranted  
!
This prospective study was undertaken to evaluate the prevalence of ANA expression and patterns 
seen with relation to patients with Scrub typhus infection needing hospitalization.  Antinuclear body 
expression was correlated with severity of illness, organ dysfunction and outcomes. Patients with 
other acute infective febrile illnesses were also assessed for ANA expression and outcomes, for 
comparison. 
!
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AIM 
!
!
To study the association between anti-nuclear antibody (ANA) expression and severity of illness, 
organ dysfunction and outcomes in Scrub typhus. 
!
!
!
!
OBJECTIVES 
!
1. To estimate the prevalence of anti-nuclear antibody expression in Scrub typhus, in comparison 
to patients with acute infective febrile illnesses other than Scrub typhus. 
2. To study the patterns of anti-nuclear antibody expressed in Scrub typhus. 
3. To study the influence of antinuclear auto-antibodies on organ dysfunction, hospital-
ization and outcomes in Scrub typhus. 
4. To study the predictive value of ANA in Scrub typhus. 
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THE BIOLOGY OF RICKETTSIAL DISEASE 
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Rickettsial disease has existed throughout the world in endemic and enzootic foci. Historically, epi-
demics of louse borne typhus have resulted in more deaths than all the wars combined.(7) The earli-
est description of typhus was by Hippocrates in 460 B.C and subsequently historical records of 
Napolean’s army having to retreat from the war with Russia in 1812 due to his army being reduced 
42 fold by typhus.(8) In recent years, there has been a re-emergence of rickettsial infections, more 
commonly reported in the tropics and amongst travellers. 
Tropical Rickettsioses refers to a group of zoonotic infections caused by organisms of the family 
Rickettsiaceae, of the order, Rickettsiales. The family includes 3 tribes- Rickettsieae, Ehrlichieae 
and Wolbachieae. The tribe Rickettsieae has 3 genera- Rickettsia, Coxiella and Rochalimaea.(9) 
This classification system continues to be modified as newer bacteria are discovered. The genus 
Rickettsia has 3 groups- 1.) the typhus group(TG) which includes R.prowazekii, R.typhi and R.-
canada; 2.) the spotted fever group(SFG) which has 20 species; 3.) the Scrub typhus group. More 
recently, studies have shown evolutionary unity of the typhus and spotted fever group, while Scrub 
typhus has been transferred to a new genus, Orientia. (1)(9) With the advent of 16S rRNA analysis 
for molecular taxonomy, there has been further reclassification.   
  
 These organisms are obligate intracellular gram negative coccobacilli that exist freely in the cytosol 
of infected arthropod hosts. They maintain intimate relations with their arthropod hosts on whom 
they are dependent for replication. Within the arthropod vectors, they multiply and are transmitted 
transovarially. The distribution of these invertebrate hosts is responsible for the extensive ecologic 
and geographic distribution of Rickettsial infections.(10)  
Arthropod hosts include ticks, fleas, mites and lice. Transmission to humans and other vertebrate 
hosts occurs through salivary secretions or faeces of the infected vector.  
!  19
Although many rickettsiae are pathogenic to humans, with the exception of R. prowazekii, the ver-
tebrate host is not essential for the life cycle of the organism.  
!
Human infection is accidental and often, a dead end. Though predominantly transmitted by the in-
fected arthropod, the aerosol and blood transfusion route have also been described. (11)  
!
The life cycle of Rickettsial organisms is closely related to the arthropod host.  The arthropod 
serves as an effective vector, reservoir and amplifier in the rickettsial life cycle. Therefore, the geo-
graphical distribution and seasonal incidence of Rickettsioses parallels that of the arthropod vector. 
!
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SCRUB TYPHUS 
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The organism causing scrub typhus was first described by the Japanese in the 1920. Hayashi pro-
posed the name Theileria tsutsugamushi and thereafter, in 1930, Nagaya and his colleagues pro-
posed Rickettsia orientalis. In 1995, the name Orientia tsutsugamushi was proposed in honour of 
the work of Hayashi and Nagaya.(1) They belong to the order, Rickettsiales, family, Rickettsiaceae 
and tribe Rickettsiae. This is the only organism to be classified under the genus Orientia. Orientia 
tsutsugamushi has exclusively been described in the eastern hemisphere.(9) 
Members of this species are rods, 1- 3 µm in length and 0.5-0.8 µm in diameter.  They are obligate, 
intracellular gram negative parasites. The most striking feature differentiating this organism from 
other species in the genus Rickettsia is that the outer leaflet of the cell wall is thicker than the inner. 
The opposite is true for other Rickettsia species. The other differentiating feature is the absence of 
peptidoglycan and lipopolysaccharide in Orientia tsutsugamushi, making the organism soft and 
fragile. Muramic acid, glucosamine and hydroxyl fatty acids are absent in the cell wall. The growth 
of this organism is also found to be more resistant to Penicillin. The major protein on the cell wall is 
the 56 kDa protein.(1) 
O. tsutsugamushi can be cultivated on the yolk sacs of developing chick embryos. It can also be cul-
tured on HeLa, Vero and BHK cell lines. The organisms exhibit intracellular growth with a predilec-
tion for the perinuclear cytoplasm. Release from the host cytoplasm is achieved by a budding 
process. A doubling time of 9- 18 hours has been described. 
More than 20 antigenic variants and strains have been described such as Karp, Gilliam, Kato, 
Shimokoshi, Kawasaki and others, on the basis of antigenic differences in the 56 kDa protein on the 
cell surface. They also differ in their virulence to mice.  Of these, the Karp strain is most endemic to 
South Asia.(5) 
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Infection is transmitted to humans and other vertebrates by mites. The organism multiplies within 
mites of the Leptotrombidium genus and is maintained in the environment by vertical or transovarial 
transmission. Trombiculid mites typically feed on wild rats. Humans get infected by the bites of 
chiggers or the larval forms of the trombiculid mite. (6) 
"  
Figure 1: Leptotrombidium deliense, the primary vector of scrub typhus 
!
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"  
Figure 2: The phylogenetic tree of Orientia tsutsugamushi. Cell surface antigen 56kDa is the 
basis for this classification 
!
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EPIDEMIOLOGY  
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Scrub typhus occurs in the eastern hemisphere. It is endemic to the ‘tsutsugamushi triangle’ formed 
by south and southeastern Asia, northern Australia and the Asia-Pacific rim.(2) This disease is typi-
cally seen in a rural or semi urban environment.(12) One million patients are affected annually and 
one billion people are at risk of this infection.(13)  
The microbe has been found to cause disease in a geographically diverse environment ranging from 
mountainous regions to tropical foL  
?LKrests covering a 13,000,000-km² area.  The organism too depicts a high degree of genotypic and 
diversity. The major factors that influence efforts to characterize antigenic subtypes appear to be the 
economic and political environment of the region, along with impact of the disease.  A mortality 
rate of ~60% was described in the pre-antibiotic era. However, recent studies have shown a down-
ward mortality trend. 
In India, the earliest records of scrub typhus are from 1917 where a typhus-like fever was described. 
The illness occurs in sporadic seasonal outbreaks commonly seen in the cooler months of August to 
October. The primary vector is L.deliense. Infection has been reported from Northern and Southern 
India.(14) An outbreak was described in Tamil Nadu is October, 2002 and subsequently this illness 
has been reported more frequently. (15) In some regions Scrub typhus constitutes upto 50 % of the 
hospitalizations for acute febrile illness.    
Though the disease is being more promptly diagnosed in indigenous populations and endemic re-
gions, diagnosis can often be a challenge, especially in the light of ecotourism and military opera-
tions. Delay in diagnosis and treatment can adversely affect prognosis and outcomes. (2)  
Scrub typhus was associated with high mortality of close to 60 % previously. However with the ad-
vent of effective antibiotic therapy, a downward trend has been noted. A recent study done in South 
India has reported a case fatality of 9 %.(6) 
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!!  
Figure 3: The ‘tsutsugamushi triangle’, endemic for scrub typhus 
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RISK FACTORS 
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In endemic areas, Scrub typhus is commonly associated with agricultural exposure. Human to hu-
man transmission is not known and various vector-related factors increase the risk of acquiring in-
fection. These include environmental and behavioural factors.(12) Understanding the same is cru-
cial to preventive and control strategies. 
Infection is commonly seen in rural or semi urban environment. (16) Outdoor activities in moist and 
humid environments put individuals at risk for infection. Farmers and forest workers are at risk and 
activities such as field work, harvesting and wood and weed gathering have a positive association. 
(17,18) Working in vegetable fields or woodland and hilly areas has been associated with risk of 
infection. Increased duration of sunshine, temperature and rainfall are positively associated with 
infection. (19) 
Living at the edge of a village or closer to farmland or grassland puts individuals at risk of exposure 
to the chiggers. Presence of a yard around the house or the practice of piling weeds indoors is also 
positively associated. (20)  
Studies have shown that men are more predisposed to infection and this may be attributed to occu-
pational trends. Behavioral risk factors include tendency to rest in direct contact with grass, use of 
clothing that increases exposure of skin to vegetation while working, lack of use of insect repellants 
and a failure to wash self or change/ dust clothes after returning from the fields. (20) Open defeca-
tion and urination and direct contact of skin with scrub vegetation predisposes to infection.(16) 
A study done in India has highlighted several risk factors. Environmental exposures include  bush-
es,  wood, fodder, domestic animals and rodents. Use of protective equipment such as aprons, boots 
and long sleeved shirts decreased risk, as also the use of insect repellants. (21) Bathing after work 
and change of clothing lowers the risk of infection. 
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Health education measures have been shown to decrease risk of infection. Education regarding 
change of clothing, avoidance of direct contact of skin to grass and use to repellants has been shown 
to decrease the incidence of infection. (16,22)   
 Risk factors associated with a fatal outcome include the absence of an eschar, higher APACHE 
scores and admission to an intensive care unit. Delay in initiation of appropriate treatment increases 
the risk of adverse outcomes. (12,23) 
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Scrub typhus is a zoonosis and the primary host of Orientia is the trombiculid mite. The organism 
multiplies and is maintained by the the arthropod host by transovarial transmission. Human infec-
tion is accidental and occurs when the chigger bites the human host and transfer of saliva containing 
the pathogen occurs. The organism multiplies at the site of inoculation and thereafter disseminates 
within the host. (3) Severity of infection is dependent on the virulence of the strain as well as host 
immunity.  
The principle site of involvement is the endothelial cell. The pathogen invades the phagocytes and 
endothelial cells. A vasculopathy ensues. The pathogenic effects are caused by disruption of the ad-
herens junctions between infected endothelial cells. This results in increased microvascular perme-
ability with subsequent leakage of fluid. (24) This vasculopathy can affect any organ ranging from 
skin to the central nervous system resulting in the protean manifestations of this disease. 
Orientia present in the saliva of the infected chigger gets inoculated and goes on to infect the den-
dritic cells and macrophages of the underlying dermis. The organism spreads lymphatogenously to 
the nodes draining the site of the eschar. This is evidenced by early development of lymphadenopa-
thy in Scrub typhus. Subsequently, there is dissemination via the hematogenous route. A predomi-
nant involvement of the endothelial cells is seen along with macrophage involvement. These cells 
release cell-specific adhesion molecules.(25) 
Host fibronectin interactions with the 56kDa type specific outer membrane protein of Orientia oc-
curs.(26) Entry into the host cell occurs via interactions with the integrin, α5β1. Signaling mole-
cules, RhoA GTPase, Src kinase and FAK (focal adhesion kinase) are activated in response to the 
external stimulus. Talin and paxillin which are signaling adaptors get recruited to the infection site. 
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Actin reorganization and membrane ruffling occurs within 10 minutes of attachment. The organism 
is phagocytosed and forms a phagosome within the endothelial cell or macrophage.(27) 
Inflammation in the dermis is initiated by the Orientia infected cells. The activated dendritic cells 
secrete inflammatory cytokines such as TNF α, IL-6, IL-13 β, MIP 1 α/β, MIP-2 and MCP-1. This 
results in the recruitment of leucocytes to the site of inflammation. (28) Chemokines of the CC sub-
family, ie, MIP 1 α/β, MCP-1 and RANTES attract lymphocytes and monocytes. Those of the CXC 
subfamily, ie MIP-2, IL-8 attract neutrophils. Stimulation of the T cells by MIP 1 α/β and RANTES 
results in a Th1 response and IFN γ production while MCP-1 stimulation results in a Th2 response 
with IL-4 production. (27)  
Endothelial cells are stimulated by the cytokines TNF-α and IL-1. This causes adhesion molecule 
up-regulation. ICAM-1, VCAM-1, P-selectin and E-selectin molecules promote cellular influx and 
further cytokine production. All of this results in a propagated local inflammatory response. Studies 
have shown that E-selectin levels in serum correlate with disease symptoms. (29)  
Although inflammation and pathogenesis is mediated via inflammatory cytokines, the organism 
also ensures survival by evasion of the immune system.(30) A Th1 cellular response with produc-
tion of INF-γ is essential for containing infection while a Th2 response is often detrimental. How-
ever mouse models have demonstrated the presence of suppressive and activating cytokines of both 
types of cellular responses, highlighting the absence of a well polarized immune response. IL-12 
stimulates T cells and natural killer cells towards a Th1 response and production of INF-γ while IL-
10 inhibits this and promotes a Th-2 response. INF-γ, in a similar fashion inhibits a Th2 response. 
Severe and life threatening complications are known to occur with scrub typhus and this may be 
related to the suppression of TNF-α and IL-6 via IL-10. This imbalance, ie, low TNF-α and high IL-
10 levels is associated with worsening condition of patients with bacterial infections.  
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A recent study has suggested that TNF-α levels can predict severity of scrub typhus in the acute in-
fectious phase. (31) Systemic release of multiple pro-inflammatory cytokines in an unregulated 
fashion has been postulated to result in SIRS. 
The role of humoral immunity in the pathogenesis of infection is not clearly understood.  Antibod-
ies may enhance phagocytosis of the infected cells by macrophages and polymorphonuclear cells. It 
may also prevent Orientia attachment, entry and replication in endothelial cells.(27)  
Immunity to infection has been complicated by the antigenic diversity and the weak cross protec-
tion among various strains. Homologous immune protection by antibodies to the 56 kDa surface 
protein too wears off after a few years.  Although profound antigenic heterogeneity deters the de-
velopment of a whole cell vaccine,  the common 56 kDa surface protein among various strains is 
being explored as a candidate for recombinant vaccine and research is underway.(27) 
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Figure 4: The organism, Orientia tsutsugamushi being phagocytosed by a macrophage  
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The clinical presentation of scrub typhus can be varied. Some of the clinical features are non- spe-
cific.  
Fever is the most common presenting symptom. It is reported by upto 98 % of patients. (32) It is of 
insidious onset and may be associated with non specific symptoms such as headache, myalgia, 
malaise and vomiting.(5) The mean duration of fever is 9±3 days. (33) 
An eschar may be found at the site of inoculation of the chigger. The appearance is that of a central 
necrotic, black crusted lesion with an erythematous halo resembling a cigarette burn. The preva-
lence of eschars have been reported in a very variable percentage of 10- 92%. (34) Eschars are 
commonly found over the chest, abdomen and hidden areas such as the axillae, groin, inframamma-
ry region and along the flexures. (35) They can provide a valuable clue to the diagnosis of scrub 
typhus.   
Leucocytosis(>11,500 cells/mm³) is present in 30% of patients and upto 70% patients have evi-
dence of thrombocytopenia(<1,50,000 cells/mm³). (5) Liver and renal function abnormalities are 
commonly seen. 
Scrub typhus can affect virtually any organ system in the body and disease manifestations are pro-
tean.  
Respiratory manifestations:  
Pulmonary symptoms are present in 60- 72% patients.(36) Breathing difficulty and cough are the 
common symptoms with or without chest infiltrates. Involvement can range from bronchitis, inter-
stitial pneumonia to severe acute respiratory distress syndrome necessitating mechanical ventilation.
(37) 
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ARDS is a dreaded respiratory complication and occurs in 11- 44% patients.(33,38) Histopathologi-
cal evaluation has shown the vasculitis and diffuse alveolar damage.(39) Upto one-third of patients 
require mechanical ventilation.(33) Predictors of ARDS include hypoalbuminemia, delay in initia-
tion of antibiotics and older age group.(38) ARDS is also associated with a high mortality rate. 
Chest radiograph abnormalities are present in 50% patients in the first week of presentation. Com-
mon findings are bilateral reticulo-nodular opacities, alveolar shadows and ARDS pattern. Pleural 
effusions, hilar adenopathy, pulmonary oedema and septal lines may also be observed. (36,37)  
Cardiac manifestations: 
Though an uncommon presentation, patients may present with features of myocarditis, cardiogenic 
shock and pulmonary oedema.  Non specific changes on ECG and rhythm abnormalities have also 
been reported.(40–42) Symptoms are reported to completely resolve following treatment. 
Hepatobiliary and gastrointestinal manifestations: 
Abdominal pain, vomiting and loose stools are common presenting symptoms. Hepatomegaly and 
splenomegaly are frequently found. GI vasculitis is the pathological process and upper GI bleeding 
has also been reported. Findings on endoscopy are that of mucosal bleeds, erosions and ulcers.
(43,44) 
Elevation of transaminases and alkaline phosphatase is seen in 70-80% patients.(33,45) A smaller 
percentage of patients have bilirubin elevation. Studies have demonstrated the presence of Orientia 
in the Kupffer cells of the liver.(28) The organism has a predilection for the hepatic sinusoidal cells, 
infiltrating the same and causes cholestasis and vasculitis in the portal area.(45) 
!
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Renal involvement: 
Acute kidney injury has been reported in 40-53% of patients with scrub typhus.(46,47) Dysfunction 
can occur secondary to systemic vasculitis, hypoperfusion of the kidneys in shock, direct invasion 
of tubules causing acute tubular necrosis, rhabdomylolysis or interstitial nephritis secondary to 
NSAID or antibiotic use.(46) Renal failure is also a definite risk factor for mortality.(5) 
Metabolic acidosis and elevated serum Creatinine levels have been associated with a poor progno-
sis.(5) 
Central nervous system manifestations: 
Headache is a common presenting symptom and is reported by 40 % of patients.(33) Upto 24 % 
patients may present with altered sensorium and 6% with seizures. Aseptic meningitis and menin-
goencephalitis are common manifestations.(48,49) Other manifestations include cerebrovascular 
injury, Guillain-Barre syndrome, movement disorders, plexopathy, neuropathy and acute dissemi-
nated encephalomyelitis. The underlying pathology is that of a vasculitis with central nervous sys-
tem involvement.(50–54) CSF studies show a lymphocytic pleocytosis with negative CSF cultures.  
!
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Scrub typhus often presents as an acute undifferentiated febrile illness that is difficult to distinguish 
from Dengue, Malaria, Leptospirosis and Enteric fever. An eschar may provide a valuable clue but 
is present in a highly variable percentage. An eschar can also be present in other rickettsial fevers 
and cutaneous anthrax. Serology is hence the mainstay of diagnostics.(55) 
Indirect immunofluorescence assay(IFA) is the current gold standard diagnostic test. Antibodies in 
the patient’s serum, bound to scrub typhus antigen is detected by fluorescent anti-human antibody.
(56) A four-fold dynamic rise in titers in paired sera is considered diagnostic. However, the  demon-
stration of a rise in titers would impede early initiation of antibiotics. Hence, a single acute serum 
cut-off antibody titer is considered diagnostic, for convenience. Studies have show that cut-offs 
range from 1:10 to 1:400.(56)  
There are several limitations to using a single acute serum antibody cut-off for diagnosis. Cut offs 
should be based on antibody titers of the local healthy population. This is important to distinguish 
background immunity from true infection, especially in areas endemic for scrub typhus. A lower 
cut-off should be used for individuals travelling to endemic areas. The antigens used in the IFA are 
Karp, Gilliam and Kato even though the antigenic heterogeneity of Scrub typhus is well known.(57) 
Organism isolation and culture has proven to be time consuming and labour intensive. The median 
time to positivity is 27 days and hence it is not useful for routine diagnosis. (56) 
Research is focused on PCR studies of eschars and blood to detect the presence of Orientia DNA or 
antigen. This method, though accurate, would be expensive.(25) 
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Many of the causes for acute febrile illness in the tropics can closely mimic scrub typhus. These 
infections should be considered in the differential diagnosis of scrub typhus. Malaria may have a 
presentation similar to scrub typhus and diagnosis is based on peripheral blood smear and other 
rapid diagnostic tests. Arbovirus infections such as Dengue and Chikungunya, Leptospirosis, Infec-
tious mononucleosis and HIV are other differentials for scrub typhus. Non infectious causes of vas-
culitis also need to be considered.  
Although serology is a valuable tool in differentiating scrub typhus from other causes, rapid defer-
vescence of fever with the use of appropriate antimicrobial therapy also aids in confirmation of di-
agnosis. 
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Severity of illness is dependent on the infecting strain, host factors and time to diagnosis and treat-
ment. Scrub typhus is associated with myriad complications due to the systemic vasculitis. Any or-
gan system may be involved and a delay in diagnosis and treatment has been associated with an in-
creased incidence in complications and mortality related to the disease. Complications of scrub ty-
phus include: 
- Lung injury and Acute respiratory distress syndrome 
- Acute kidney injury 
- Central nervous system complications such as aseptic meningitis and seizures 
- Hepatitis, pancreatitis and gastrointestinal vasculitic ulcers  
- Myocarditis with shock  
- Hematological complications such as hemophagocytosis 
- Sepsis with MODS and septic shock.                                                                                       
Previous studies on scrub typhus reported a high mortality rate of 60% secondary to multi organ 
dysfunction. However, recent studies have demonstrated a decreasing mortality trend with a more 
recent study reporting a case fatality rate of 9%. 
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The first drug to be used in the treatment of Scrub typhus was Chloramphenicol and reports of the 
use of this drug date back to the 1940s. However, due to the issues of bone marrow suppression and 
aplastic anaemia, this drug has been used less frequently in the recent years. Tetracyclines are the 
mainstay of treatment and are the most commonly used drugs in treatment of scrub typhus. Studies 
have compared the efficacy of single dose versus a one week course of Doxycyline. The use of 
Doxycyline is associated with gastrointestinal side effects and Tetracycline use is contraindicated in 
pregnancy due to teratogenicity and use in young children has been associated with staining of the 
teeth. Macrolides such as Azithromycin were later introduced in the treatment of scrub typhus. Ad-
vantages include a shorter course of antibiotics with fewer gastrointestinal side effects. However, 
macrolide use has been associated with transient elevation of liver enzymes and the cost of 
Azithromycin is significantly higher than Doxycyline. 
In recent years, Quinolones and Rifampicin have also been used in the treatment of this infection 
with good results. Quinolones such as Levofloxacin were found to be less efficacious in patients 
with multi-organ dysfunction and higher APACHE scores. Use of Rifampicin is also associated with 
multiple side effects and issues of spread of Rifampicin resistant tuberculosis has resulted in sparse 
use of this drug in the treatment of Rickettsial infection.  
There has been an increased incidence of reports of Doxycycline resistance in northern Thailand. In 
such cases use of Azithromycin and Rifampicin is recommended. In patients with severe infection, 
parenteral therapy with Azithromycin has been found to be more effective than oral Doxycycline. 
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Prevention of infection- Scrub typhus is a zoonotic disease. Infection can be prevented by taking 
precautionary measures especially during exposure to scrub vegetation and during the cooler 
months. Use of insecticide repellants and appropriate personal protective equipment such as socks 
and long sleeved clothing has been proven to be effective in preventing infection. Dusting of cloth-
ing and footwear and baths after visiting an endemic area can prevent infection. Control of rodent 
and marsupial reservoirs can prevent the vectors from entering areas where human beings live and 
work. 
!
Prophylaxis against scrub typhus- Use of Doxycycline and Azithromycin once a week  during 
and 6 weeks after exposure has been found to be effective in the prevention of stub typhus. 
Research is underway in the development of an effective vaccine for prevention of Scrub typhus. 
Hurdles in the development of a vaccine include a large range of genotypic variants and differences 
in geographical distribution of the various strains. Infection with one strain does not confer immuni-
ty to infection by another strain.  
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Antibodies to nuclear antigens are found in the serum of patients with systemic autoimmune dis-
ease.  They were first described in the 1940s by Hargraves while studying the Lupus Erythematosus 
(LE) cell – phagocytosis of nuclei of disrupted cells was promoted by these autoantibodies.  The LE 
cell is a phagocyte with an ingested nucleus. The LE cell test has been replaced in most laboratories 
by newer tests with greater sensitivity and specificity. The development of an Immuno-fluorescent 
assay (IFA) for detection of antinuclear antibodies has been a big milestone in immunology. Further 
sub-classification of antinuclear antibodies into individual, specific antigen-antibody reactions has 
been made possible by the use of purified nucleic acid antigen substrates.(58) Current immunologi-
cal tests can detect 10-12 antigen-antibody specificities using recombinant or biochemically puri-
fied antigens. They are of great importance in the context of diagnostics and prognostication of 
rheumatologic conditions. 
Although classically described in the setting of autoimmune disease, studies have shown that au-
toantibodies may also be detected in healthy individuals. (59) The prevalence of antinuclear anti-
bodies in healthy individuals in 3-15%. These antibodies have also been found to occur in patients 
with chronic infections such as Hepatitis C, bacterial endocarditis, HIV infection, tuberculosis and 
lepromatous leprosy.(60) Drug induced lupus secondary to Procainamide, Hydralazine, Isoniazid, 
Penicillamine and anti-TNF-alpha therapy is also associated with positive antinuclear antibodies.
(61)  Antibodies are also found in greater frequency in women and with increasing age.  
Indirect immunofluorescent test is considered as the most reliable screening test for antinuclear an-
tibodies. Diluted human serum is placed on frozen mouse liver or kidney sections. Fluorescent con-
jugates of anti-human gamma globulin is used to detect the presence of autoantibody attached to the 
mouse antigen. Titers of antinuclear body are known to vary greatly.(58)  
!
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The ANA pattern is also of importance and four major patterns have been recognized: homogenous 
or solid, peripheral or rim, nucleolar and speckled patterns. 
- The homogenous pattern is associated with connective tissue disease and drug induced lu-
pus. 
- The speckled pattern is seen in SLE, RA, Sjogren’s syndrome and systemic sclerosis 
- The peripheral rim pattern is seen in SLE and correlates with antibodies to dsDNA 
- The nuceolar pattern is seen is scleroderma and to lesser extent in Sjogren’s syndrome and 
SLE.(62) 
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Figure 5: Patterns of antinuclear antibodies and the associated diseases 
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The pathogenic mechanism leading to the formation of autoantibodies is poorly understood.(63) 
Environmental triggers such as infections can trigger autoimmune diseases in genetically predis-
posed individuals. Studies have shown that living in an infectious environment from a young age 
favours the formation of autoantibodies. This may be attributed to molecular mimicry between the 
nuclear components of infectious agents and normal cells. However, they do not predict develop-
ment of lupus.(64)  
Non autoimmune patients have demonstrated presence of autoantibodies during acute bacterial, vi-
ral, parasitic and rickettsial infections such as ANA, ASCA, LA, etc.(60) Autoantibodies have also 
been found with greater frequency in patients with tropical infections and chronic diseases such as 
tuberculosis, leishmaniasis, leprosy and Hepatitis B and C. The most common pattern is the speck-
led type. This may represent neutrophil activation or molecular mimicry rather than true autoim-
mune disease. The absence of demonstrable antibodies to DNA or extractable nuclear antigens sug-
gests that this may be a non-specific manifestation of immune system activation. An article studying 
the same has recommended caution in the interpretation of auto-antibody tests in persons with trop-
ical infections and subjects from the tropics.(65) 
Autoantibody production has been studied in considerable detail in patients with malaria since the 
70s. Recent immunofluorescence studies have demonstrated the presence of cytoplasmic diffuse, 
nuclear speckled fluorescent patterns of antinuclear antibodies in chronic malaria. This expression 
can suggest molecular mimicry or polyclonal antibody stimulation resulting in antibodies directed 
at self-targets. The study has also suggested use of immunofluorescent studies for early detection of 
disease, hence aiding early treatment.(66)  
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Clinical manifestations of scrub typhus are a result of vasculitis caused by infection. Anti-nuclear 
antibody expression has been observed in Scrub typhus and it is likely that it is a non specific ex-
pression, as can occur in 10 percent of patients in the absence of an autoimmune disease. In a pilot 
study of 40 patients with severe scrub typhus infection admitted to the intensive care unit, 16 (40%) 
were tested positive for ANA. We postulated that patients who manifest multi-organ dysfunction in 
severe Scrub typhus may have a nonspecific expression of this immunological marker. For prognos-
tic significance, we evaluated if the expression of this antibody was associated with a higher inci-
dence of organ dysfunction and poorer outcomes in scrub typhus.  
This prospective study was undertaken to evaluate the prevalence of ANA expression and patterns 
seen with relation to patients with Scrub typhus infection needing hospitalization. ANA expression 
was correlated with severity of illness at presentation as assessed by the Sequential Organ Failure 
Assessment (SOFA) as well as the Acute Physiology and Chronic Health Evaluation (APACHE) III 
scores. In addition, ANA positivity was correlated with organ dysfunction and outcome. 
Patients admitted to hospital with a diagnosis of scrub typhus were evaluated. Data on demograph-
ics, organ dysfunction, organ support required and outcomes was collected in pre-constructed data 
abstraction form. ANA expression was correlated with severity of illness, organ dysfunction, length 
of stay and mortality.  Patients with acute infective febrile illnesses other than Scrub typhus were 
similarly assessed for ANA expression, for comparison. 
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Study type: Analytical 
Study design: Prospective, observational study 
We used two methodologies in this study. In the estimation of prevalence of antinuclear bodies, we 
used a case control design where patients with other acute febrile illnesses were used as the control 
arm. For studying the correlation of antinuclear antibodies with outcomes in scrub typhus, a cohort 
design was employed.  
Setting: This study was conducted in the Department of Medicine, Christian Medical College, Vel-
lore. Christian Medical College is a 2500-bedded tertiary care hospital situated in Vellore in the 
state of Tamil Nadu, South India. Previous studies done in this hospital have shown that Scrub ty-
phus constitutes 47 % of all acute febrile illnesses requiring admission.(4)  
Duration of study: Patients were recruited from January, 2013 to January, 2014 for the study.   
Study population: Adult patients hospitalised in the medical wards with an acute febrile 
illness(AFI), fulfilling the diagnostic criteria for Scrub typhus infection and other acute infective 
febrile illnesses(controls) were included in the study. After obtaining a written consent from patients 
fulfilling the inclusion criteria, the necessary demographic data and the data regarding the current 
illness and investigations were collected.  
Inclusion criteria- Cases 
1. Patients aged >16 years 
2. Undifferentiated febrile illness of <21 days 
3. Fulfilling diagnostic criteria for Scrub typhus infection 
4. No other evident (focus of) infection following initial clinical evaluation 
!
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Inclusion criteria- controls 
1. Patients aged >16 years 
2. Acute febrile illness of <21 days 
3. Not fulfilling diagnostic criteria for Scrub typhus 
4. Matched for age and sex with the cases. 
!
Exclusion criteria 
1. Patients on immunosuppression  
2. Patients with known underlying auto-immune disorders or malignancy 
3. Patients who were on medications known to cause ANA positivity prior to the current illness, 
like sulphasalazine, Praziquantel, procainamide, isoniazid, hydralazine and certain anticon-
vulsants. 
4. Patients unwilling to participate 
!
Withdrawal criteria 
1. Patients unwilling to continue participation in the study 
2. Patients discharged against medical advice 
!
Sources of information 
1. Laboratory testing 
2. Study participants or relatives 
3. Hospital records 
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Outcome measures  
The following outcomes were planned and specifically assessed in this study 
• Primary outcome-  
o Estimation of the prevalence and patterns of antinuclear antibodies in Scrub typhus, 
in comparison to control groups. 
o Correlation of antinuclear antibody positivity with organ dysfunction in scrub typhus, 
as assessed by the SOFA and APACHE III scoring systems 
!
• Secondary outcomes- 
o Duration of hospital stay in Scrub typhus categorized by ANA expression 
o Duration of ICU stay in Scrub typhus categorized by ANA expression 
o Deaths due to Scrub typhus infection categorized by ANA expression 
!
Diagnostic criteria for Scrub typhus  
- AFI and the presence of a positive eschar and Scrub IgM ELISA, or; 
- AFI plus a positive Scrub IgM ELISA plus defervesence within 48 hours of  initiation of 
Doxycycline  
Patients with a negative Scrub IgM ELISA who had an eschar were not included in the study. 
!
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We also looked at organ dysfunction in the study population. 
- Myocarditis: clinically and pathologically defined as “inflammation of the myocardium” (Ameri-
can Heart Association); evidenced by ECG and ECHO changes and elevation of cardiac en-
zymes. 
- Acute Respiratory distress syndrome(ARDS): acute lung injury of less than 1 week duration, with 
bilateral opacities on imaging, with no evidence of cardiac failure  
- mild ARDS: P/F ratio 201- 300 mmHg  
- moderate ARDS: P/F ratio 101- 200 mmHg  
- severe ARDS:  P/F ratio ≤ 100 mmHg 
(Berlin, 2012, guidelines) 
- Acute kidney injury: Abrupt (within 48 h) reduction in kidney function defined as  
- an absolute increase in serum creatinine of 0.3 mg/dL or more (≥26.4 µmol/L) or 
- A percentage increase in serum creatinine of 50% or more (1.5-fold from baseline) or 
- A reduction in urine output (documented oliguria of < 0.5 mL/kg/h for >6 h) 
(AKIN guidelines) 
- Aseptic meningitis: the clinical presentation and cerebrospinal fluid (CSF) findings that include 
lymphocyte-predominant pleocytosis of fewer than 500 cells/µL, normal glucose concentration, 
normal or slightly elevated protein, and negative bacterial antigen tests. 
!
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Sample size calculation: 
Unpublished data of research done in CMC had shown a 40% prevalence of ANA positivity in  
scrub typhus infection.  
Prevalence of ANA positivity in other acute infective febrile illnesses was estimated at approxi-
mately 15%. (Studies done in Ghana on patients with malaria showed a 24 % positivity for ANA 
expression) 
Sample size : 
!
"  
!
!
Taking the prevalence of ANA expression in scrub typhus as 40% and prevalence in other acute 
febrile illnesses estimated at 15%, with an alpha error of 0.05 and a power of 80%, the number of 
patients required in each group was calculated to be 60. 
In this study, we included 89 cases and 60 controls. 
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Methodology 
Step 1: Recruitment 
Since this was a prospective study, all patients were recruited after an explanation of the study and 
the protocol. In the event that the patient was sedated or in an altered state of consciousness, con-
sent was obtained from the nearest relative or guardian accompanying the patient (Annexure I). 
Scrub typhus and antinuclear antibody serologies were sent within 24 hours of admission in the 
hospital. 
Step 2: Data collection 
All consecutive patients admitted in the hospital medical wards fulfilling inclusion criteria were re-
cruited. Data was collected in data abstraction forms (Annexure II).  
The following data was collected specifically: 
1. Baseline demographic data- Age, sex, occupation 
2. History of co-morbidities such as diabetes, hypertension, coronary artery disease 
3. History related to the acute febrile illness such as duration and associated symptoms 
4. Examination findings 
5. Laboratory parameters  
6. Complications of the acute febrile illness- shock, acute respiratory distress syndrome, renal 
failure, myocarditis and aseptic meningitis 
7. Scrub typhus serology 
8. Anti-nuclear antibody serology 
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9. Laboratory variables necessary for computing serial SOFA scores on day 1, 3 and 5. 
10.Laboratory variables necessary for computing APACHE III score at admission 
11.Duration of ICU stay 
12.Duration of hospital stay 
13.Duration of mechanical ventilation and duration of vasoactive agent use.  
14.Clinical outcomes 
!
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Laboratory assessment of Scrub typhus 
Serological diagnosis of scrub typhus was done by using the Immunoglobulin M enzyme linked 
immunosorbent assay, IgM ELISA, which utilises indirect immunofluorescence. This test uses the 
56 kDA antigen. A conclusive diagnosis of scrub can be made only on the basis of a > four fold rise 
in titers in paired sera drawn at least 2 weeks apart. In the presence of adequate clinical evidence, a 
single sample may suffice. 
!
!
Laboratory assessment of Antinuclear antibody 
Antinuclear antibodies in serum are detected by the principle of indirect immunofluorescence.  This 
test utilises the Human epidermoid carcinoma cell line or the HEp-2 cells. These cells are fixed on 
slides with solvent and diluted human serum is added and incubated. The slides are washed and the 
cells are subsequently incubated with fluorescent antibodies to human immunoglobulins. Slides are 
examined using an ultraviolet microscope. After a In this study patterns of fluorescence such as 
homogenous, speckled, nuclear, etc can be studied. By adding saline and diluting the serum, the 
titer reading is determined. Serial dilutions are done to the patient’s serum and the end point is when 
less than half of the cells on the slide show detectable fluorescence. 
!
!
!
!
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Step 3: Statistical Analysis 
All study variables were described using descriptive statistical methods. Continuous variables 
which were summarized using mean and standard error.  
The continuous variables were studied between the study and control groups and those with positive 
and absent ANA expression using two sample t-test or Mann-Whitney U test. Paired t- test was used 
for repeat samples of ANA. 
Dichotomous variables were compared using chi-square or Fisher’s exact test.  
Bivariate analysis and logistic regression analysis was used to find correlation between ANA posi-
tivity and outcomes. 
Data was entered and analyzed using SPSS software ( Statistical Package for Social Sciences, Ver-
sion 20, IBM, New York , United States of America).  
!
!
!
!
!
!
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Funding 
The cost of the anti-nuclear antibody serology was borne by the institution through a grant allotted 
by the institutional review board for this specific purpose.  
ANA serology was done at a cost of Rs. 490 per sample processed. 
Scrub IgM ELISA was done at a cost of Rs. 725 per sample processed. 
!
Institutional Research Board approval and ethical considerations: 
Consent was obtained at admission, before testing for anti-nuclear antibodies. Institutional Research 
Board (IRB) approval was obtained prior to commencement of the study. 
Institutional ethics committee reviewed the study design and no major ethical concerns were raised. 
!
!
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!
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!
!
!
RESULTS 
!
!
!
!
!
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This prospective study was carried out in the Department of General Medicine, in-patient wing 
from January, 2013 to January, 2014. A total of 89 patients with Scrub typhus and 60 patients with 
other acute febrile illnesses were included in this study 
 
!
 
 
 
 
 
 
 
!
 
!
!
Figure 6: Strobe diagram of the progress through phases of the study 
!
!
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89 patients in-
cluded in study
Controls  (Other acute 
ANA
ANA 
(Within 24 hours)
Follow up
Organ Dysfunction 
Duration of ICU stay 
Hospital stay
Follow up  
➢ 6 weeks
Deaths
Repeat ANA
342 patients with scrub typhus 
admitted 
Jan, 2013-Jan, 2014
PATIENT DEMOGRAPHICS 
Table 1: Baseline characteristics of the study population 
NUMBER PERCENTAGE
AGE (years)!!
16-30!!
31-50!!
51-70!!
>70!!
Mean: 46.48!
95% CI: 43.16-50
!!
15!!
37!!
24!!
13
!!
16.9!!
41.6!!
27!!
14.6
GENDER!
MALE!!
FEMALE
!
38!!
51
!
42.7!!
57.3
OCCUPATION!!
Professional!
Skilled!
Unskilled!
Unemployed!
!!
2!
5!
32!
50
!!
2.2!
5.6!
36!
56.2
LOCATION!!
Vellore!
Chittoor!
Other!!
!!
53!
27!
9
!!
59.6!
30.3!
10.1
RISK/CO-MORBIDITY!!
Bronchial asthma!
Diabetes mellitus!
Diabetes, hypertension!
HIV infection!
Hypertension!
Mental retardation!
Pregnancy!
Nil
!!
1!
12!
2!
2!
13!
1!
3!
55
!!
1.1!
13.5!
2.2!
2.2!
14.6!
1.1!
3.4!
61.8!
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The mean (±SD) age was 46.5 (16.9) with a range of 17-85 years. The number of male and female 
patients with scrub typhus was nearly equal though a slight female preponderance was observed, 
with a female to male ratio of 1.34:1.   A significant proportion of patients were from Vellore 
(59.6%) and the other major area of residence was Chittoor, Andhra Pradesh (30.3%). Most patients 
were either engaged in unskilled work or unemployed. 
!
!
!
!
!
!
!
!
!
!
!
!
!
!
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CLINICAL PROFILE OF PATIENTS WITH SCRUB TYPHUS 
Fever was the most common presenting symptom and was present in all patients with a mean dura-
tion of 7.79 (95% CI 7.09-8.53) days. The other common presenting symptoms included myalgia 
(n=50) and breathlessness (n=49). 
!
Table 2: Profile of symptoms in scrub typhus patients recruited in the study (duration in days) 
!
!
                 NUMBERS                MEAN (Days)                  95% CI
FEVER 89 7.79 7.09-8.53
HEADACHE 36 5.92 4.92-6.97
NAUSEA/VOMITING 44 4.14 3.45-4.86
RASH 2 4.5 4-5
COUGH 22 4.32 3.36-5.23
ALTERED SENSORI-
UM
8 1.13 1-1.38
MYALGIA 50 6.16 5.32-7.06
ABDOMINAL PAIN 22 4.73 4.05-5.41
BREATHLESSNESS 49 3.63 3.10-4.18
ARTHRALGIA 6 4.33 3.33-5
JAUNDICE 6 6.17 2.83-10
OLIGURIA 7 1.71 1.14-2.43
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An eschar was noted in 75.3% (n=67) patients with scrub typhus, in this study. Tachycardia, defined 
as a heart rate above 100/min and tachypnea, defined as a respiratory rate above 24/min, was 
present in 80.9%(n=72) patients. At the time of assessment, 36%(n=32) patients were febrile. Dif-
fuse respiratory crepitations were present in 58.4%(n=52) patients and 52.8%(n=47) patients had 
bilateral infiltrates on chest radiograph.  
Table 3: Profile of signs in scrub typhus patients recruited in this study 
!
!
                                                
NUMBERS
                                          PER-
CENTAGE
PALLOR 17 19.1
ICTERUS 16 18
LYMPHADENOPATHY 1 1.1
VISIBLE RASH 2 2.2
OEDEMA 9 10.1
ESCHAR 67 75.3
TACHYCARDIA [HR >100/MIN] 72 80.9
TACHYPNOEA [RR > 24/MIN] 72 80.9
HYPOTENSION [BP <90/60] 19 21.3
FEVER [>100 F] 32 36
HEPATOMEGALY 16 18
SPLENOMEGALY 14 15.7
CREPITATIONS 52 58.4
NECKSTIFFNESS 4 4.5
CHESTINFILTRATES 47 52.8
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Table 4: Profile of laboratory parameters of patients recruited in the study 
!
!
!
MINIMUM MAXIMUM MEAN STANDARD 
ERROR
Hb [g%] 7.9 16.5 11.8 0.201
WBC count 
[cell/mm3]
4300 22,700 11,149 426.87
% Neutrophils 36 96 73.12 1.34
Platelets 4000 290000 81898 6608
S.Creatinine 
[mg/dl]
0.57 4.98 1.48 0.08
S.Sodium 
[mmol/L]
115 157 131 0.70
S.Potassium 
[mmol/L]
2.4 5.6 3.8 0.05
S.Bicarbonate 
[mmol/L]
8.3 30 19.14 0.44
CPK [mg%] 24 5313 831.8 519.18
Total bilirubin 
[mg%]
0.2 11.4 2.20 0.25
Direct Bilirubin 
[mg%]
0.1 9.8 1.66 0.21
Protein [g/dl] 4.7 8.3 6.3 0.08
Albumin [g/dl] 1.4 4.3 2.76 0.06
SGOT [mg%] 34 604 149 11.3
SGPT [mg%] 10 574 87.5 7.6
Alkaline phos-
phatase [mg%]
37 617 185 11.7
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The laboratory parameters of the patients with scrub typhus showed that most patients had leucocy-
tosis with a neutrophil predominance.  
Thrombocytopenia was a common finding with a mean platelet count of 81,898/mm3.  
The mean Hemoglobin was 11.8gm%. No major electrolyte abnormalities were noted in the pa-
tients. 
CPK levels were at borderline levels with mean of 831.8 mg%. 
Renal dysfunction was present in a significant proportion  of patients with a mean serum creatinine 
of 1.48 mg/dl.  
Hepatic dysfunction in the form of transaminitis was a common finding. 
!
!
!
!
!
!
!
!
!
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!
  COMPLICATIONS OF SCRUB TYPHUS 
 
!
!
Figure 7: Organ system involvement in scrub typhus 
!
!
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!
!
!
!
Table 5: Complications of scrub typhus, numbers and percentages of patients. 
!
!
!
!
!
!
!
!
NUMBERS PERCENTAGE
ACUTE RESPIRATORY DIS-
TRESS SYNDROME
51 57.3
SHOCK 25 28.1
MYOCARDITIS 7 7.9
ACUTE KIDNEY INJURY 32 36
ASEPTICMENINGITIS 8 9
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The most common complication of scrub typhus observed in this study was acute respiratory dis-
tress syndrome (ARDS). It was present in 51(57.3%) patients. Shock and acute kidney injury were 
present in 28.15(n=25) and 36%(n=32) patients respectively. Other complications such as aseptic 
meningitis and myocarditis was less commonly observed. Majority of patients had one to three or-
gan systems that were dysfunctional.  
!
!
!
Figure 8: Complications in scrub typhus patients. 
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PRIMARY OUTCOME: 
!
!
I: ESTIMATION OF PREVALENCE AND PATTERNS OF ANTINUCLEAR ANTIBODIES 
IN SCRUB TYPHUS, IN COMPARISON WITH CONTROL GROUPS 
!
ANTINUCLEAR ANTIBODIES IN PATIENTS WITH SCRUB TYPHUS 
!
Of the 89 patients with scrub typhus recruited for the study, serology revealed presence of anti-nu-
clear antibodies in 78.65%(n=70) patients. Excluding patients who showed weak positive expres-
sion of anti-nuclear antibodies, 53.93(n=48)% had anti-nuclear antibodies. 
 For all further analysis, cases of weak ANA positivity were included with the cases that were nega-
tive for ANA expression. 
!
!
!
!
!
!
!
!  80
!
!
 
!
Figure 9: Prevalence of anti-nuclear antibodies in patients with Scrub typhus 
!
!
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!
!
PATTERNS OF ANTI-NUCLEAR ANTIBODY EXPRESSION 
Of the 48 patients with positive anti-nuclear antibodies, 93.75%(n=45) had a speckled pattern and 
6.25%(n=3) had a speckled and nucleolar pattern of anti-nuclear antibodies. 
Figure 10: Patterns of antinuclear antibody expression in scrub typhus  
!
!
!
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COMPARISON OF SCRUB TYPHUS CASES WITH CONTROLS WITH OTHER ACUTE 
FEBRILE ILLNESSES 
In this study, controls were not adequately matched with scrub typhus patients for age and sex. The 
p value for age group was 0.046 and for gender was 0.008. Hence, age group and gender was ad-
justed in further analysis. 
!
Table 6: Comparison of characteristics of scrub typhus patients with controls with acute 
febrile illnesses!
!
CASE CONTROL
AGE!!
16-29!
30-49!
50-69!
>=70
!!
15!
37!
24!
13
!!
16!
13!
24!
7
GENDER!!
MALE!
FEMALE
!!
38!
51
!!
39!
21
ANA !!
POSITIVE!
NEGATIVE
!!
41!
48
!!
9!
51
ANA TITRE!!
Negative!
1+!
2+!
3+!
Weak+!
Negative with cytoplasmic 
fluorescence
!!
16!
23!
22!
3!
22!
3
!!
50!
3!
6!
0!
0!
1
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PREVALENCE OF ANTINUCLEAR ANTIBODIES IN CASES IN COMPARISON WITH 
CONTROLS 
While the prevalence of antinuclear antibodies was 53.93% in patients with scrub typhus, patients 
with other acute febrile illnesses had an antinuclear antibody prevalence of 15%. This difference 
was found to be statistically significant with a p value of <0.001. 
!
Figure 11: Prevalence of antinuclear antibodies in scrub typhus in comparison with other 
acute febrile illnesses. 
!
!
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COMPARISON OF ANTINUCLEAR ANTIBODY PREVALENCE DURING AND 6 WEEKS 
AFTER ILLNESS- IN SCRUB TYPHUS 
!
While the prevalence of antinuclear antibodies was 53.93% in patients with scrub typhus, on repeat-
ing the test for 32 people after a period of 6 weeks, only 5 persisted to be ANA positive(15.62%). 
This data shows that there is a  trend towards returning to baseline ANA positivity in the general 
population.  
!
!
!
Figure 12: Prevalence of antinuclear antibodies during and 6 weeks after illness (ANA repeat) 
in patients with scrub typhus 
!
!
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NEGATIVE POSITIVE
!
II CORRELATION OF ANTINUCLEAR ANTIBODY EXPRESSION WITH ORGAN DYS-
FUNCTION IN SCRUB TYPHUS 
!
CORRELATION OF ANTINUCLEAR ANTIBODY POSITIVITY AND SOFA, APACHE III 
AND MODS 
!
On bivariate analysis of antinuclear antibody positivity with organ dysfunction as assessed by the 
Sequential Organ Failure Assessment scoring that was done on day 1, 3 and 5 of admission, no cor-
relation was found. The multiple organ dysfunction score also showed no correlation with anti-
nuclear antibody positivity. However, bivariate analysis of the Acute physiology and chronic health 
evaluation (APACHE) III showed a correlation with antinuclear antibody positivity and this was 
found to be tending towards statistical significance (p= 0.07). Antinuclear antibody positivity pre-
dicted higher APACHE III scores. 
!
!
!
!
!
!
!
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!
!
Table 8: Bivariate analysis of ANA positivity with SOFA Day 1, 3 and 5, MODS and 
 APACHE III scores 
!
!
!
!
!
!
!
!
!
!
ODDS 
RATIO
95% CONFIDENCE INTERVAL P VALUE
SOFA Day 1 1.06 0.94- 1.19 0.32
SOFA Day 3 1.06 0.94- 1.20 0.32
SOFA Day 5 1.00 0.85- 1.18 0.938
Mutliple Organ 
dysfunction score
1.25 0.92- 1.69 0.14
APACHE III SCORE 1.01 0.99- 1.03 0.07
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CORRELATION OF ANTINUCLEAR ANTIBODY POSITIVITY WITH ORGAN DYS-
FUNCTION AND COMPLICATIONS OF SCRUB TYPHUS 
!
Table 9: Bivariate analysis of complications of scrub typhus and ANA positivity 
!
!
!
Table 10: Bivariate analysis of individual parameters of SOFA D1 and ANA positivity 
!
!
!
ODDS RATIO 95% CONFIDENCE 
INTERVAL
p VALUE
MYOCARDITIS 2.20 0.40- 12.05 0.36
RENAL FAILURE 1.01 0.42- 2.45 0.96
SHOCK 1.08 0.42- 2.75 0.42
ARDS 2.44 1.02- 5.80 0.04
ASEPTIC MENINGITIS 6.65 0.72- 56.63 0.08
ODDS RATIO 95% CONFIDENCE 
INTERVAL
p VALUE
CARDIAC [SOFA] 0.78 0.29- 2.14 0.64
CNS [SOFA] 3.79 0.75- 19.04 0.10
HEMATOLOGY [SOFA] 0.83 0.24- 2.87 0.77
RENAL [SOFA] 1.01 0.43- 2.35 0.43
LIVER [S0FA] 2.25 0.94- 5.39 0.06
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Bivariate analysis of organ dysfunction in scrub typhus with antinuclear antibody positivity re-
vealed a positive correlation with acute respiratory distress syndrome [OR- 2.44, 95% CI- 1.02- 5.8, 
p= 0.04]. There was a correlation with development of aseptic meningitis, which showed a trend 
towards statistical significance [OR- 6.65, 95% CI- 0.72- 56-63, p= 0.08]. On bivariate analysis of 
individual parameters of sequential organ failure assessment(SOFA) score, day 1, a positive correla-
tion was found with hepatic dysfunction and antinuclear antibody presence [OR- 2.25, 95% CI- 
0.94- 5.39, p- 0.06]. 
!
!
!
!
!
!
!
!
!
!
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SECONDARY OUTCOMES 
I. ANTINUCLEAR ANTIBODIES AND DURATION OF HOSPITAL STAY IN SCRUB TY-
PHUS 
On bivariate analysis, there was no correlation between antinuclear antibodies and duration of hos-
pital stay. 
!
II. ANTINUCLEAR ANTIBODIES AND DURATION OF ICU STAY IN SCRUB TYPHUS 
On bivariate analysis, there was no correlation between antinuclear antibodies and duration of ICU 
stay. 
!
III.  ANTINUCLEAR ANTIBODY POSITIVITY AND MORTALITY IN SCRUB TYPHUS 
On bivariate analysis, there was no correlation between antinuclear antibody and mortality in scrub 
typhus. 
!
Table 11: Bivariate analysis of antinuclear antibody positivity and duration of hospital stay, 
duration of ICU stay and mortality in scrub typhus 
!
ODDS RATIO 95% CONFIDENCE IN-
TERVAL
P VALUE
ICU STAY 0.87 0.71- 1.06 0.17
HOSPITAL STAY 0.94 0.85- 1.04 0.29
HOSPITAL OUTCOME 0.58 0.05- 0.67 0.67
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!
!
 
!
!
Figure 13: Scatter plot of Antinuclear antibodies in patients with scrub typhus and ICU stay 
(in days) 
!
!
!
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!
!
 
!
Figure 14: Scatter plot of Antinuclear antibodies in patients with scrub typhus and Hospital 
stay(in days) 
!
!
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!
!
 
!
!
!
!
!
!
!
!
!
!
!
!
Figure 15: Antinuclear antibodies in patients with scrub typhus and mortality (n=numbers in 
the bar chart) 
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DISCUSSION 
To the best of our knowledge, this is the first study that has prospectively evaluated prevalence of 
anti-nuclear antibody expression and outcomes in patients with scrub typhus.  
Prevalence and patterns of antinuclear antibodies in patients with scrub typhus: 
The prevalence of antinuclear antibodies in patients with scrub typhus was 53.93%. In the control 
arm, antinuclear antibodies were present in 15%. This difference was found to be statistically signif-
icant ( p value <0.01 ). The prevalence of antinuclear antibodies in the general population is esti-
mated at 3 to 15%. This study has highlighted that patients with scrub typhus have a significantly 
higher expression of antinuclear antibodies. On including cases which showed weak positivity for 
antinuclear antibodies, the prevalence was as high as 78.65%. Repeat antinuclear antibody tests 
were performed in 32 patients after a period of 6 weeks- 5(15.6%) patients persisted to have anti-
nuclear antibodies. This suggests a return to the baseline antinuclear antibody positivity rate of the 
general population.  
The presence of autoantibodies in scrub typhus could suggest molecular mimicry and a non specific 
activation of the immune system. Since the pathogenesis of scrub typhus involves an infectious sys-
temic vasculitis, presence of these autoantibodies could be a result of the same. Inflammation and 
stimulation of polyclonal antibody formation probably induces autoantibody formation against self 
antigens. Antinuclear antibodies have been previously detected in patients with malaria, tuberculo-
sis and other infections. The decrease in titres after 6 weeks suggests that antinuclear antibodies in 
scrub typhus may not be a manifestation of true autoimmunity or portend risk of developing lupus. 
Decrease in titres and absence of antibodies after the convalescence period may also suggest that 
these autoantibodies may be acute phase reactants. 
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The principle site of involvement in scrub typhus is the endothelial cell which results in a vascu-
lopathy and increased microvascular permeability. This has been postulated as the reason for the 
protean manifestations of this disease ranging from skin to central nervous system involvement. In-
flammation is mediated via cytokines and a Th1 response with formation of IFN-γ is essential for 
containment of infection. Recent studies have demonstrated that TNF-α levels can predict severity 
of illness. 
Humoral immunity in scrub typhus is not well studied and at present, its role in infection is not 
clear. Further studies are essential to further understand the mechanism and pathogenesis behind 
autoantibody formation in scrub typhus.  
In this study, the most commonly expressed pattern of antinuclear antibodies was the speckled pat-
tern(93.75%). The speckled pattern of antinuclear antibodies is seen in autoimmune diseases such 
as lupus, mixed connective tissue disease, polymyositis and Sjogren’s syndrome. This pattern has 
also been recently observed in patients with malaria. A recent study has used presence of speckled 
pattern of antinuclear antibodies as a surrogate marker for detection of chronic malaria.  
The rest of the patients who had positive antinuclear antibodies expressed a speckled and nucleolar 
pattern(6.25%).  3(3.37%) patients had a cytoplasmic fluorescence pattern. The reason behind the 
expression of the speckled pattern of antinuclear antibodies needs to be studied further for better 
understanding.  
!
!
!
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Antinuclear antibodies and outcomes in scrub typhus 
On bivariate analysis, we did not find a correlation between antinuclear antibody positivity and se-
quential organ failure assessment scores on day 1, 3 and 5 of admission. There was no correlation 
with multi organ dysfunction scores. However, bivariate analysis f the APACHE III scores and anti-
nuclear antibody positivity showed correlation which was tending towards statistical significant. 
[OR- 1.01, 95%CI- 0.99- 1.03,  p- 0.07].  
On analysis of the individual organ systems involved, it was noted that antinuclear antibodies corre-
lated with the development of ARDS [ OR- 2.44, 95% CI- 1.02- 5.80, p- 0.04]. The development of 
neurological complications such as aseptic meningitis also appeared to correlate with a trend to-
wards clinical significance [OR- 6.65, 95% CI- 0.72- 56.63, p-0.08]. It is also interesting to note 
that all patients who developed seizures with scrub typhus were positive for antinuclear antibodies. 
On assessment of the individual parameters of the SOFA scores on day 1, it was found that a corre-
lation existed between antinuclear antibody positivity and hepatic dysfunction, which also showed a 
trend towards significance [OR- 2.25, 95% CI- 0.94- 5.39, p- 0.06] 
Hence, on analysis of outcomes, antinuclear antibodies showed a positive correlation with APACHE 
III scores and the development of neurological, hepatic and respiratory complications of scrub ty-
phus.  
Antinuclear antibodies and duration of hospital and ICU stay 
On analysis, no correlation was found between the presence of antinuclear antibodies in scrub ty-
phus and the duration of hospitalisation. Antinuclear antibody positivity had no effect on the dura-
tion of ICU stay in these patients with scrub typhus.  
!
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Mortality in scrub typhus and antinuclear antibodies 
There were 3 deaths due to scrub typhus in this study. The mortality was 3.37%.  On bivariate 
analysis, no correlation was found between mortality due to scrub typhus and the presence of anti-
nuclear antibodies. 
!
!
!
!
!
!
!
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!
LIMITATIONS 
!
• A small sample size has been an important limitation in our study. The sample size under each 
subgroup was too small to perform tests of significance in a meaningful manner.  
• The second limitation was that the controls were not adequately matched for age, sex and other 
confounding variables.  We have taken some steps to adjust for this in the analysis.  
• Controls were included in the study to adjust for the presence of anti-nuclear antibody presence 
in other infections.  
• Another important limitation was the non-availability of repeat ANA samples in a significant 
number of patients who initially tested positive for anti-nuclear antibodies.  
• In our analysis, we have attempted to adjust for all potential confounders. However, the possibil-
ity of other unmeasured confounders cannot entirely be excluded. 
• In this study, antinuclear antibodies were found in a significant number of cases in comparison 
with controls. However, antinuclear antibody had no correlation with outcomes or severity of 
illness in our analysis. It may be that the sample size studied was not adequately powered to de-
tect a significant difference in outcomes. This study highlights the need for further studies in this 
area to understand the mechanism of autoantibody production in scrub typhus and the signifi-
cance of the same. 
!
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!
CONCLUSIONS 
!
• In patients with Scrub typhus, antinuclear antibodies are found in a significant proportion of pa-
tients.  
• This is significantly different from the antinuclear antibody positivity seen in other acute febrile 
illness. 
• It appears to be an acute phenomenon, as there is a tendency for antinuclear antibodies to be-
come negative after the acute phase of illness.   
• Antinuclear antibody positivity was not found to correlate with the sequential organ failure as-
sessment(SOFA) scores, duration of hospital stay or mortality.  
• However, a correlation was found between antinuclear antibody positivity and APACHE III 
scores, suggesting that presence of these antibodies may predict a worse outcome.  
!
!
!
!
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!
• We also noted a significant correlation between the presence of antinuclear antibodies and the 
development of neurological, respiratory and hepatic complications in scrub typhus, further sug-
gesting a vasculitic mechanism behind these complications. 
• This may be an epiphenomenon or there may be a true causal relationship.  
• Further studies of larger numbers are required to understand the mechanisms and implications of 
antinuclear antibody production in scrub typhus. 
!
!
!
!
!
!
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ANNEXURE I- PATIENT INFORMATION AND CONSENT SHEET !
Anti nuclear antibody expression and its relationship to severity of illness, organ 
dysfunction and outcomes in Scrub typhus 
Information sheet 
!
You are being requested to participate in a study to see if anti-nuclear body expression 
is present in Scrub typhus and to see whether it can be used to predict outcomes in 
Scrub typhus infection. We hope to include about 90 people from this hospital in this 
study. 
What is Scrub typhus? 
Scrub typhus is a febrile illness commonly seen in South India, especially during the 
cooler months. 
It is caused by rickettsiae and is transmitted by the bites of infected, immature 
mites(chiggers) that normally reside on rats. 
It is not transmitted directly from person to person. 
Infection leads to an inflammation of blood vessels- ‘vasculitis’.  This has a wide variety 
of manifestations such as fever, headache, cough, rash etc. 
Patients are found to have this disease on the basis of classical signs like an eschar and 
blood tests like the IgM ELISA  
Occasionally some patients are found to have a more severe form of illness with a poor 
outcome.   
What is ANA and how is it related to Scrub typhus? 
Antibodies are proteins that are made as part of an immune response. Anti nuclear anti-
body is an antibody or a substance of immunity that the body produces, which fights 
against the person’s own body. Some patients with Scrub typhus also express this anti-
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body. We are attempting to study if this antibody leads to a poor outcome in patients 
with Scrub typhus. 
If you take part what will you have to do? 
If you agree to participate in this study, we will perform some additional blood tests on 
you, such as the ANA and Scrub IgM ELISA tests. Thereafter, we will follow you during the 
course of your illness to assess how your body is coping with the illness and also to look 
out for any serious damage caused by the illness.  
Can you withdraw from this study after it starts? 
Your participation in this study is entirely voluntary and you are also free to decide to 
withdraw permission to participate in this study. If you do so, this will not affect your 
usual treatment at this hospital in any way.  
What will happen if you develop any study related injury? 
There will be no injury related to this study as we are only performing an additional 
blood test on you, with relation to the study.  
Will you have to pay for the ANA blood test?  
The additional blood test being done for the study will be free of cost. All other treat-
ment of Scrub typhus will continue according to the hospital’s treatment protocol and 
the usual arrangements that you have with the hospital will decide how much you pay 
for this.  
What happens after the study is over? 
We will follow you up during the course of your illness and stay in hospital. The results 
of this study may be used in future for the treatment of scrub typhus. 
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 CONSENT TO TAKE PART IN A CLINICAL TRIAL 
Study Title: Anti nuclear antibody expression and its relationship to severity of illness, 
organ dysfunction and outcomes in Scrub typhus. 
Study Number:  
Participant’s name:  
Date of Birth / Age (in years): 
I_____________________________________________________________ 
___________, son/daughter of  ___________________________________ 
!
• Declare that I have read the information sheet provide to me regarding this study 
and have clarified any doubts that I had 
• I also understand that my participation in this study is entirely voluntary and that 
I am free to withdraw permission to continue to participate at any time without 
affecting my usual treatment or my legal rights  
• I understand that I will receive free treatment for any study related injury or ad-
verse event but I will not receive any other financial compensation  
• I understand that the study staff and institutional ethics committee will not need 
my permission to look at my health records even if I withdraw from the trial. I 
agree to this access   
• I understand that my identity will not be revealed in any information released to 
third parties or published  
• I voluntarily agree to take part in this study  
!
Name: 
Signature: 
Date: 
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ANNEXURE II- DATA ABSTRACTION FORM ANA EXPRESSION IN SCRUB TYPHUS 
!
Name:     Age:    Sex: Male / Female  
Address:                                                                                 Occupation: !
                                                                                                Contact number: !
Risk factors/Co-morbidities:  !
Symptomatology at presentation: 
!!
Signs: 
!!
Investigations: 
Symptomatology Duration of 
symptom
Symptomatology Duration of 
symptom
Fever Myalgia        
Headache Abdominal pain               
Nausea/Vomiting Breathlessness    
Rash   Arthralgia
Cough  Jaundice 
Altered sensorium Oliguria 
Seizures Bleeding 
Pallor  
   
Tachycardia>100              
   
Splenomegaly 
Icterus                      SpO2                                      Petechiae 
Lymphadenopathy                                            Tachypnea >20 Crepitations 
Rash Hypotension<90 Altered sensorium
Oedema Fever Neck stiffness
Eschar   Hepatomegaly LV S3
Hb   Potassium               
   
Protein 
TLC                      Bicarbonate                             Albumin 
% Neutrophils                                             CPK SGOT 
Platelets  Total bilirubin SGPT 
Creatinine Direct bilirubin ALP 
Sodium SGOT Chest infiltrates
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Serial No: Hospital No:
!!
SOFA details:  
!!
!!!
Other complications: 
!!!
Use of Vasoactive agents:                     Duration: !!
Ventilation and duration : !
Ventilated: Yes / No    NIV  /  Invasive      Duration of ventilation : NIV___ INV____ !!
Duration of ICU stay (days):             Duration of hospital stay (days): !!
Hospital outcome:  Dead / Alive / Discharged at request  Probable cause(s) of death:                                                    !!
Bill: !
ANA Pattern and titer Repeat 
ANA
Parameter Day 1 Day 3 Day 5
Respiratory
Platelets
Vasoactive
GCS score
Bilirubin score
Renal score
TOTAL SCORE
DAY 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
RIFLE
VENTILATION
VASOACTIVES
ARDS Myocarditis Aseptic meningitis
          Shock Renal failure [RIFLE] Pulmonary embolism
!  114
"  !
!  115
ANNEXURE III- LIST OF TABLES AND FIGURES 
A. FIGURES 
Figure 1: Leptotrombidium deliense, the primary vector of scrub typhus 
Figure 2: The phylogenetic tree of Orientia tsutsugamushi. Cell surface antigen 56kDa is the 
basis for this classification 
Figure 3: The ‘tsutsugamushi triangle’, endemic for scrub typhus 
Figure 4: The organism, Orientia tsutsugamushi being phagocytosed by a macrophage  
Figure 5: Patterns of antinuclear antibodies and the associated diseases 
Figure 6: Strobe diagram of the progress through phases of the study 
Figure 7: Organ system involvement in scrub typhus 
Figure 8: Complications in scrub typhus patients 
Figure 9: Prevalence of anti-nuclear antibodies in patients with Scrub typhus 
Figure 10: Patterns of antinuclear antibody expression in scrub typhus 
Figure 11: Prevalence of antinuclear antibodies in scrub typhus in comparison with other 
acute febrile illnesses. 
Figure 12: Prevalence of antinuclear antibodies during and 6 weeks after illness (ANA repeat) 
in patients with scrub typhus 
Figure 13: Antinuclear antibodies in patients with scrub typhus and ICU stay 
Figure 14: Antinuclear antibodies in patients with scrub typhus and Hospital stay 
Figure 15: Antinuclear antibodies in patients with scrub typhus and mortality 
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B. TABLES 
Table 1: Baseline characteristics of the study population 
Table 2: Profile of symptoms in scrub typhus patients recruited in the study (duration in days) 
Table 3: Profile of signs in scrub typhus patients recruited in the study 
Table 4: Profile of laboratory parameters of patients recruited in the study 
Table 5: Complications of scrub typhus, numbers and percentages of patients. 
Table 6: Comparison of characteristics of scrub typhus patients with controls with acute 
febrile illnesses 
Table 7: Comparison of ANA during and 6 weeks after illness 
Table 8: Bivariate analysis of ANA positivity with SOFA Day 1, 3 and 5, MODS and APACHE 
III scores 
Table 9: Bivariate analysis of complications of scrub typhus and ANA positivity 
Table 10: Bivariate analysis of individual parameters of SOFA D1 and ANA positivity 
Table 11: Bivariate analysis of antinuclear antibody positivity and duration of hospital stay, 
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ANNEXURE IV- STANDARD OPERATION PROTOCOL 
1. THE SEQUENTIAL ORGAN FAILURE ASSESSMENT (SOFA) SCORE CALCULAT-
ED  ON DAY 1, 3 AND 5 OF ADMISSION. 
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2.  THE ACUTE PHYSIOLOGY AND CHRONIC HEALTH EVALUATION (APACHE) III 
SCORING SYSTEM 
!  
The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized 
adults.!
W A Knaus; D P Wagner; E A Draper; J E Zimmerman; M Bergner; P G Bastos; C A Sirio; D J Murphy; T 
Lotring; A Damiano 
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